Lindner Center of HOPE
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Lindner Center of HOPE sits in the top decile of US sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count).
Lindner Center of HOPE: 23 sponsored US clinical trials, none currently recruiting.
Lindner Center of HOPE sponsors 23 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 18 completed. 18 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Panic Disorder, with 1 trials.
Top-decile sponsor footprint
Lindner Center of HOPE ranks in the top decile of sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
18 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
23 total, page 1 of 1
Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
NCT03158805
Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)
NCT02659475
N-acetylcysteine in Bulimia Nervosa
NCT01131572
Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder
NCT01090713
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
NCT01131559
Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
NCT01093963
N-acetylcysteine in the Treatment of Bulimia Nervosa
NCT01033149
Armodafinil in Binge Eating Disorder (BED)
NCT01010789
A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain
NCT00363376
Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance
NCT00585208
Sodium Oxybate in the Treatment of Binge Eating Disorder
NCT00514995
Acamprosate in the Treatment of Binge-Eating Disorder
NCT00511940
Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
NCT00438776
Bipolar II Depression: Lithium, SSRI, or the Combination
NCT00276965
A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression
NCT00363337
Atomoxetine in the Treatment of Binge Eating Disorder
NCT00327834
Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity
NCT00277641
Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
NCT00279617
Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
NCT00221442
Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms
NCT00277667
Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder
NCT00277654
Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania
NCT00278772
Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation
NCT00280839
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 5 |
| Phase 3 | 16 |
| Phase 4 | 2 |
Therapeutic Areas
How the Lindner Center of HOPE archive is shaped
23 indexed studies, none listed as recruiting (0% open); 18 completed (78%).
Phase mix: 18 late (III/IV) vs 5 early (I/II) (later-stage heavy).
Top condition: Panic Disorder (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Lindner Center of HOPE: archived-pipeline peers nationwide
Peers matched on 23 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Lindner Center of HOPE sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 23 archived trials
- AMAG Pharmaceuticals · 23 trials · 9% recruiting
- AtriCure · 23 trials · 22% recruiting
- Cara Therapeutics · 23 trials · 0% recruiting
- Craig L Slingluff, Jr · 23 trials · 4% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Lindner Center of HOPE page
23 registered trials is a research-attention snapshot, not an endorsement of Lindner Center of HOPE or any single study.
- None of Lindner Center of HOPE's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Panic Disorder is the condition Lindner Center of HOPE studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Panic Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Lindner Center of HOPE pipeline card: 23 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.